About Ansa Research
Ansa Research is a company based in Bengaluru (India) founded in 2009 by N K Venkataramana. The company has 18 employees as of April 01, 2024. Ansa Research operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter Bengaluru, India
- Employees 18 as on 01 Apr, 2024
- Founders N K Venkataramana
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Advanced Neuro- Science Allies Private Limited
- Date of Incorporation 12 May, 2009
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$300.59 (USD)0as on Mar 31, 2023
-
Net Profit
-$94.91 (USD)37.6as on Mar 31, 2023
-
EBITDA
-$286.58 (USD)-1035as on Mar 31, 2023
-
Latest Funding Round
-
Investors
-
Employee Count
18
as on Apr 01, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ansa Research
Investments & Acquisitions by Ansa Research
Financial Statements - Ansa Research
Ansa Research Comparisons
Competitors of Ansa Research
Ansa Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
Latest news on Ansa Research
Frequently Asked Questions about Ansa Research
Ansa Research was founded in 2009.
Ansa Research is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
As of Apr 01, 2024, the latest employee count at Ansa Research is 18.
Annual revenue of Ansa Research is $300.59 as on Mar 31, 2023.
ANSA was established in 2009 in Bengaluru, India, as an RD entity in the biotechnology sector. Focus is placed on stem cell research targeting neurological disorders, with the branded product anScell derived from healthy voluntary donors. Research-grade GMP-compliant mesenchymal stem cells are supplied for in vitro and research applications. A Tumor Tissue Repository for brain tumors is maintained to support cancer research. Backing is provided by Birthstone Capital.
Ansa Research's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.